Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.25 (-0.89%)
At close: Dec 31, 2025
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.15 billion as of December 31, 2025. Its market cap has increased by 29.04% in one year.
Market Cap
3.15B
Enterprise Value
2.69B
Revenue
491.23M
Ranking
n/a
PE Ratio
288.43
Stock Price
27.70
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.15B, an increase of 373.96%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 174.75B |
| Lotus Pharmaceutical | 73.63B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 30.94B |